LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,110 | 8,060 | 7,120 | 9,380 | 12,840 |
| Marketable Securities | 33,550 | 31,830 | 35,370 | 8,960 | 8,790 |
| Other current assets | 410 | 590 | 1,080 | 660 | 430 |
| TOTAL | $69,070 | $40,480 | $43,570 | $19,000 | $22,060 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,910 | 1,740 | 1,670 | 1,630 | 1,560 |
| TOTAL | $1,910 | $1,740 | $1,670 | $1,630 | $1,560 |
| Total Assets | $71,880 | $43,010 | $45,870 | $21,250 | $24,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 800 | 460 | 310 | 210 | 280 |
| Accrued Expenses | 4,550 | 2,760 | 2,250 | 990 | 1,010 |
| TOTAL | $5,370 | $3,270 | $2,640 | $1,340 | $1,460 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $20 |
| Total Liabilities | $5,370 | $3,270 | $2,640 | $1,340 | $1,480 |
| Shareholders' Equity | |||||
| Common Shares | 350 | 290 | 290 | 240 | 240 |
| Retained earnings | -92,110 | -85,560 | -81,860 | -77,630 | -74,640 |
| Other shareholders' equity | 190 | 110 | 0 | 0 | 0 |
| TOTAL | $66,500 | $39,740 | $43,220 | $19,910 | $22,810 |
| Total Liabilities And Equity | $71,870 | $43,010 | $45,860 | $21,250 | $24,290 |